{
    "2018-05-08": [
        [
            {
                "time": "2018-05-15",
                "original_text": "任性并购的苦果谁来负责？ 沉沦的佐力药业",
                "features": {
                    "keywords": [
                        "并购",
                        "佐力药业",
                        "责任"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-16",
                "original_text": "公募基金仓位超六成 医药股成新宠？",
                "features": {
                    "keywords": [
                        "公募基金",
                        "医药股",
                        "仓位"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-17",
                "original_text": "[强于大市评级]医药行业周报：中美贸易摩擦持续看好医药牛市 推荐智飞生物、康泰生物、贝瑞基因等",
                "features": {
                    "keywords": [
                        "医药行业",
                        "牛市",
                        "智飞生物",
                        "康泰生物",
                        "贝瑞基因",
                        "中美贸易摩擦"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-18",
                "original_text": "公募基金今年忙着“吃药” 医药基金该怎么选",
                "features": {
                    "keywords": [
                        "公募基金",
                        "医药基金",
                        "投资策略"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-19",
                "original_text": "医药板块持续活跃近10股涨停 新光药业6天5板领衔",
                "features": {
                    "keywords": [
                        "医药板块",
                        "涨停",
                        "新光药业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "惊呆了！10家药企研发投入近90亿",
                "features": {
                    "keywords": [
                        "药企",
                        "研发投入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-21",
                "original_text": "独角兽成色几何：药明康德持续盈利能力需进一步观察",
                "features": {
                    "keywords": [
                        "独角兽",
                        "药明康德",
                        "盈利能力"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "[增持评级]医药与健康护理行业月报：积极拥抱医药 业绩、估值与政策叠加共振",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "业绩",
                        "估值",
                        "政策"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-23",
                "original_text": "北上资金加码流入 A股两领域优质股或现新布局点",
                "features": {
                    "keywords": [
                        "北上资金",
                        "A股",
                        "优质股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "A股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-24",
                "original_text": "“独角兽”药明康德今日上市 这几只股有望率先受益",
                "features": {
                    "keywords": [
                        "独角兽",
                        "药明康德",
                        "上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-25",
                "original_text": "【金工】2018年年中主要宽基指数样本股调整预测：市场流动性下降导致冲击系数普遍上升",
                "features": {
                    "keywords": [
                        "金工",
                        "宽基指数",
                        "样本股调整",
                        "流动性"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-26",
                "original_text": "重磅抗癌新药上市提速 君实、信达生物抢位战开打",
                "features": {
                    "keywords": [
                        "抗癌新药",
                        "君实",
                        "信达生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-27",
                "original_text": "北向资金延续净买入态势",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-28",
                "original_text": "公募基金今年持续加仓医药股",
                "features": {
                    "keywords": [
                        "公募基金",
                        "医药股",
                        "加仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-29",
                "original_text": "公募基金最具“巴菲特眼光” 40个季度季季持有“股神标准”9只股",
                "features": {
                    "keywords": [
                        "公募基金",
                        "巴菲特眼光",
                        "股神标准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}